A study of circulating anti-CD25 antibodies in non-small cell lung cancer

L Ye; X Li; S Sun; S Guan; M Wang; X Guan; K-H Lee; J Wei; B Liu

doi:10.1007/s12094-012-0980-2

A study of circulating anti-CD25 antibodies in non-small cell lung cancer

L Ye
, X Li
, S Sun
, S Guan
, M Wang
, X Guan
, K-H Lee
, J Wei
, B Liu

Resultado de pesquisa: Article › revisão de pares

15 Citações (Scopus)

Resumo

Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

Idioma original	English
Páginas (de-até)	633-7
Número de páginas	5
Revista	Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Volume	15
Número de emissão	8
DOIs	https://doi.org/10.1007/s12094-012-0980-2
Estado da publicação	Published - ago. 2013

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

Good health and well being

Acesso ao documento

10.1007/s12094-012-0980-2

Citar isto

Ye, L., Li, X., Sun, S., Guan, S., Wang, M., Guan, X., Lee, K.-H., Wei, J., & Liu, B. (2013). A study of circulating anti-CD25 antibodies in non-small cell lung cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 15(8), 633-7. https://doi.org/10.1007/s12094-012-0980-2

@article{2b606b9114434f008339ff53a87cf3d7,

title = "A study of circulating anti-CD25 antibodies in non-small cell lung cancer",

abstract = "Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.",

author = "L Ye and X Li and S Sun and S Guan and M Wang and X Guan and K-H Lee and J Wei and B Liu",

year = "2013",

month = aug,

doi = "10.1007/s12094-012-0980-2",

language = "English",

volume = "15",

pages = "633--7",

journal = "Clinical \& Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico",

issn = "1699-3055",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "8",

}

Ye, L, Li, X, Sun, S, Guan, S, Wang, M, Guan, X, Lee, K-H, Wei, J & Liu, B 2013, 'A study of circulating anti-CD25 antibodies in non-small cell lung cancer', Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 15, n.º 8, pp. 633-7. https://doi.org/10.1007/s12094-012-0980-2

TY - JOUR

T1 - A study of circulating anti-CD25 antibodies in non-small cell lung cancer

AU - Ye, L

AU - Li, X

AU - Sun, S

AU - Guan, S

AU - Wang, M

AU - Guan, X

AU - Lee, K-H

AU - Wei, J

AU - Liu, B

PY - 2013/8

Y1 - 2013/8

N2 - Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

AB - Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

U2 - 10.1007/s12094-012-0980-2

DO - 10.1007/s12094-012-0980-2

M3 - Article

C2 - 23263913

SN - 1699-3055

VL - 15

SP - 633

EP - 637

JO - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

JF - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

IS - 8

ER -

A study of circulating anti-CD25 antibodies in non-small cell lung cancer

Resumo

ODS da ONU

Acesso ao documento

Impressão digital

Citar isto